Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes.
about
Severe community-acquired meningitis.Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis.Treatment of bacterial meningitis.Inhibition of intracellular growth of Listeria monocytogenes by antibiotics.Triclosan-induced aminoglycoside-tolerant Listeria monocytogenes isolates can appear as small-colony variants.Comparative efficacies of antibiotics in a rat model of meningoencephalitis due to Listeria monocytogenes.Use of aminoglycosides in treatment of infections due to intracellular bacteriaBacterial Meningitis: Principles and Practical Aspects of Therapy.In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.Sublethal triclosan exposure decreases susceptibility to gentamicin and other aminoglycosides in Listeria monocytogenesManagement of listeriosis.In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes.Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin.In vivo antibiotic synergism: contribution of animal models.Use of rifampin in nonstaphylococcal, nonmycobacterial disease.Animal models of listeriosis: a comparative review of the current state of the art and lessons learned.Chemotherapy for bacterial infections of the central nervous system.In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenesSusceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.Rifampin for therapy of experimental pneumococcal meningitis in rabbits.Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.Pharmacokinetics and bacteriological efficacy of mezlocillin in experimental Escherichia coli and Listeria monocytogenes meningitis.
P2860
Q24795217-42611653-2744-42CA-A2E4-4631B8EC5930Q30449424-AB21F181-E844-4F0F-AD6E-E67061580289Q30451337-FF60C3FD-46D5-408F-BCCF-B52B60555185Q30451354-40AAB2EA-E377-4F27-BA32-54F36A026774Q33544695-85102B8C-D116-491D-A3B6-8E9A0D04B686Q33750449-A6BE4A61-C73D-42F0-9471-49EEBEA97BB3Q33797966-59F768B6-1F12-4264-A5E6-42D7530DC3A8Q33977123-2514BDD4-3BED-4782-9046-A0DA0AF96151Q33983252-707A9C50-8B38-4C58-8CAE-2F43E5337C51Q34092272-56286CEB-7931-442B-9AB7-293F6C9A028BQ35139159-3582F436-F31C-4738-9F9E-AA7F3BE5C31BQ35191619-A0493983-BB66-4C89-9D59-28CED9608B85Q35374228-01650859-8E30-401F-A593-5911DE784D70Q35712742-D47DF58F-0BE6-4C4C-AC8F-65D75C0FAB6EQ35740417-CCF82AA6-EF35-46ED-8F15-57F73E5410D0Q35754023-F9234D03-9220-4779-A38D-3452FDBFBC3FQ35807365-DDE259CA-0D0E-45A4-B042-994357C2EFBDQ36062235-1D2DAB0A-95E5-4293-B59F-97451D5FD0F2Q39676532-05F8374A-5F68-4948-BD71-C7443353B523Q39834431-D3B1C9EA-B44A-4243-A954-4E9204E04FBEQ39855023-51384859-6E17-4B45-B15A-20026E585DFFQ39856486-2B265049-61C5-4A6A-B70D-7257EFC66553Q39866960-13D24336-DC9A-419C-BD8C-9F505DFD9DF7Q40200463-17E2442B-3E5F-4877-A55B-F0A7B823E23AQ40447370-4097E480-A4C3-4A9C-B3E4-47DA1BA9FB32Q42929829-DCBCC7E8-4920-4C73-BD38-B55BB7BC6224
P2860
Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Response to therapy in an expe ...... due to Listeria monocytogenes.
@en
Response to therapy in an expe ...... due to Listeria monocytogenes.
@nl
type
label
Response to therapy in an expe ...... due to Listeria monocytogenes.
@en
Response to therapy in an expe ...... due to Listeria monocytogenes.
@nl
prefLabel
Response to therapy in an expe ...... due to Listeria monocytogenes.
@en
Response to therapy in an expe ...... due to Listeria monocytogenes.
@nl
P2093
P356
P1476
Response to therapy in an expe ...... due to Listeria monocytogenes.
@en
P2093
P304
P356
10.1093/INFDIS/140.3.287
P407
P577
1979-09-01T00:00:00Z